Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler

Archives of Internal Medicine

Volumn 159, Issue 17, 1999, Pages 2033-2038

  Hajek, Peter ^a   West, Robert ^b   Foulds, Jonathan ^b,c,d   Nilsson, Fredrik ^e   Burrows, Sylvia ^b   Meadow, Anna ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e Pharmacia & Upjohn AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE GUM; NOSE SPRAY;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INHALER; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SMOKING CESSATION; SUBSTITUTION THERAPY; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; ADULT; CHEWING GUM; COTININE; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; POLYMETHACRYLIC ACIDS; POLYVINYLS; SALIVA; SMOKING CESSATION;

EID: 0033610278     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.17.2033     Document Type: Article

References (13)

1. Silagy C, Mant D, Fowler G, Lancaster T. Nicotine Replacement Therapy for Smoking Cessation [serial on CD-ROM]. Oxford, England: Update Software; 1999.
2. Fagerstrom KO, Schneider N, Lunell E. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology. 1993;111:271-277.
3. Leischow S, Valente S, Hill A, et al. Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence. Exp Clin Psychopharmacol. 1997;5:54-64.
4. Benowitz N, Zevin S, Jacob P. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Br J Clin Pharmacol. 1997;43:259-267.
5. Hajek P, Jarvis M, Belcher M, Sutherland G, Feyerabend C. Effect of smoke-free cigarettes on 24 h cigarette withdrawal: a double-blind placebo-controlled study. Psychopharmacology. 1989;97:99-102.
6. Rose J, Levin E. Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. Br J Addict. 1991;86:605-609.
7. West R, Russell M. Pre-abstinence smoke intake and smoking motivation as predictors of severity of cigarette withdrawal symptoms. Psychopharmacology. 1985; 87:334-336.
8. Gorsline J. Nicotine pharmacokinetics of four nicotine transdermal systems. Health Values. 1993;17:20-24.
9. Hughes J, Wadland W, Fenwick J, Lewis J, Bickel W. Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study. Prev Med. 1991; 20:489-496.
10. Sutherland G, Stapleton J, Russell M, et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet. 1992;340:324-329.
11. Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F. A double-blind trial of nicotine inhaler in smoking cessation. JAMA. 1993;269:1268-1271.
12. Killen J, Fortmann S, Newman B, Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol. 1990;58:85-92.
13. Hajek P. Helping smokers to overcome tobacco withdrawal: background and practice of withdrawal-oriented therapy. In: Richmond R, ed. Interventions for Smokers: An International Perspective. Baltimore, Md: Williams & Wilkins; 1994:29-46.